Top Markets
Coin of the day
CSL Limited CSL Limited

CSL Limited

CSL
주식 순위 #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
주가
$99.32
시가총액
$48.20B
변동 (1일)
0.98%
변동 (1년)
-32.14%
국가
AU
거래 CSL Limited (CSL)

카테고리

CSL Limited (CSL)의 매출
Dec 2025 기준 매출 TTM: $15.70B
CSL Limited의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $15.70B입니다. 2024년에 회사는 $14.69B의 수익을 올렸으며 이는 2023년의 $13.17B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
CSL Limited의 수익 기록 (2000 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $15.70B 1.72%
2025 $15.43B 5.04%
2024 $14.69B 11.51%
2023 $13.17B 25.55%
2022 $10.49B 1.56%
2021 $10.33B 9.84%
2020 $9.41B 13.08%
2019 $8.32B 11.54%
2018 $7.46B 6.28%
2017 $7.02B 15.81%
2016 $6.06B 11.00%
2015 $5.46B 8.91%
2014 $5.01B 10.79%
2013 $4.52B -2.44%
2012 $4.64B -3.37%
2011 $4.80B 49.63%
2010 $3.21B 6.25%
2009 $3.02B -7.53%
2008 $3.26B 42.87%
2007 $2.28B 45.52%
2006 $1.57B -1.58%
2005 $1.60B 98.59%
2004 $803.28M 36.45%
2003 $588.71M 38.88%
2002 $423.90M -2.21%
2001 $433.49M 0.00%
2000 0.00 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$48.55B 209.32%
DK
$12.04B -23.30%
US
$14.34B -8.62%
US
$9.08B -42.13%
BE
$5.49B -65.01%
NL